Hussman Strategic Allocation Fund
Hussman Strategic Allocation Fund (HSAFX)
The Hussman Strategic Allocation Fund (HSAFX) is a mutual fund that focuses on strategic asset allocation to achieve long-term growth and income for investors. The fund is managed by Hussman Investment Trust and invests in a mix of stocks, bonds, and cash equivalents. HSAFX aims to provide a balanced and diversified portfolio, with a focus on risk management and downside protection. This fund is suitable for investors looking for a conservative approach to investing with a long-term horizon.
HSAFX Mutual Fund Chart & Stats
- Previous Close
- $10.48
- Sub-Category
- Asset Allocation
- Total Liabilities
- $8.69M
- Expense Ratio
- 1.31%
- Holding Count
- 208
- Brand
- Hussman Investment Trust
- Category
- Alternative
- Total Assets
- 32.89M
- Shares Outstanding
- N/A
- 52-Week Range
- $9.58 - $10.49
HSAFX Mutual Fund News
Neurocrine Updates Rare Epilepsy Study as NBI-921352 Trial Ends
Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Study Overview: Neurocrine Biosciences’ official Phase 2 study, “A Prospective, Long-Term, Interventional, Active Extension Study to Evaluate the Safety
HSAFX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHSHORT-TERM INVESTMENTS TRUST | 37.65% |
| USD_CASHUNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 8.38% |
| USD_CASHUNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 2.19% |
| USD_CASHUNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 2.06% |
| USD_CASHUNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 1.98% |
| PEPPepsico | 1.01% |
| UIUbiquiti Networks Inc | 0.99% |
| INCYIncyte | 0.94% |
| VSATViaSat Inc | 0.93% |
| NBIXNeurocrine Biosciences | 0.91% |
| Total | 57.02% |
Recently Viewed
No data currently available






